Improving dynamic prognostication of patients with hepatocellular carcinoma by node fusion algorithm equipped survival path mapping.

被引：0
|
作者：
Shen, Lujun, Sr.
Jiang, Yiquan
Fan, Wei-Jun
机构：
[1] Sun Yat Sen Univ Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ Canc Ctr, Dept Minimally Invas Intervent Therapy, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13594
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Positive Lymph Node Metastasis Has a Marked Impact on the Long-Term Survival of Patients with Hepatocellular Carcinoma with Extrahepatic Metastasis
    Xia, Feng
    Wu, Lin
    Lau, Wan-Yee
    Li, Guo
    Huan, Hongbo
    Qian, Cheng
    Ma, Kuansheng
    Bie, Ping
    PLOS ONE, 2014, 9 (04):
  • [32] Sentinel lymph node mapping using SPECT-CT fusion imaging in patients with oral cavity squamous cell carcinoma
    Keski-Santti, Harri
    Matzke, Sorjo
    Kauppinen, Tomi
    Tornwall, Jyrki
    Atula, Timo
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2006, 263 (11) : 1008 - 1012
  • [33] Treatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolization
    Prajapati, Hasmukh J.
    Kim, Hyun S.
    PLOS ONE, 2017, 12 (02):
  • [34] The PATH score based on pathological grade predicts survival of patients with advanced hepatocellular carcinoma after hepatic arterial infusion chemotherapy.
    Lai, Jinfa
    Lyu, Ning
    Zhao, Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [35] Cell Pair Algorithm-Based Immune Infiltrating Cell Signature for Improving Outcomes and Treatment Responses in Patients with Hepatocellular Carcinoma
    Zhang, Xiao
    Xie, Jun
    He, Dan
    Yan, Xin
    Chen, Jian
    CELLS, 2023, 12 (01)
  • [36] K-Means Algorithm-Assisted Clustering of Patients and Survival Analysis, Based on mRNA Expressivity in the Tumor Microenvironment of Hepatocellular Carcinoma (HCC)
    Lee, Sunyoung
    Lee, Seongwon
    Kim, Jin Cheon
    Park, Shinyoung
    Baird, Andrew
    Dolan, Jillian
    HEPATOLOGY, 2018, 68 : 548A - 549A
  • [37] Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy
    Chen, Bang-Bin
    Hsu, Chao-Yu
    Yu, Chih-Wei
    Liang, Po-Chin
    Hsu, Chiun
    Hsu, Chih-Hung
    Cheng, Ann-Lii
    Shih, Tiffany Ting-Fang
    RADIOLOGY, 2016, 281 (02) : 454 - 464
  • [38] Improving care quality of hepatocellular carcinoma by early survival analysis of established patients' database: an example on patients in BCLC early to intermediate stage treated by surgical resection or radiofrequency ablation
    Wang, J-H
    Chen, C-L
    Kee, K-M
    Hu, T-H
    Cheng, Y-F
    Lu, S-N
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A165 - A165
  • [39] Loss of heterozygosity at D8S298 is a predictor for long-term survival of patients with tumor-node-metastasis stage I of hepatocellular carcinoma
    Pang, Jin-Zhong
    Qin, Lun-Xiu
    Ren, Ning
    Hei, Zhen-Yu
    Ye, Qing-Hai
    Jia, Wei-Dong
    Sun, Bing-Sheng
    Lin, Guo-Ling
    Liu, Dao-Yong
    Liu, Yin-Kun
    Tang, Zhao-You
    CLINICAL CANCER RESEARCH, 2007, 13 (24) : 7363 - 7369
  • [40] Dynamic contrast-enhanced magnetic resonance imaging biomarkers predict survival and response in hepatocellular carcinoma patients treated with sorafenib and metronomic tegafur/uracil
    Hsu, Chao-Yu
    Shen, Ying-Chun
    Yu, Chih-Wei
    Hsu, Chiun
    Hu, Fu-Chang
    Hsu, Chih-Hung
    Chen, Bang-Bin
    Wei, Shwu-Yuan
    Cheng, Ann-Lii
    Shih, Tiffany Ting-Fang
    JOURNAL OF HEPATOLOGY, 2011, 55 (04) : 858 - 865
12345